ArticleLipids2026
Cashew Nut Oil Improves Lipid Metabolism and Fat Liver Deposition in High-Fat Diet-Fed C57BL/6J Mice.
Article in Lipids, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Protective Effects of Cashew Apple Bagasse and Its Hydroethanolic Extract Against Fatty Liver in Rats.Antioxidants (Basel, Switzerland) · 2026Article
- Cashew Nut Oil Improves Lipid Metabolism and Fat Liver Deposition in High-Fat Diet-Fed C57BL/6J Mice.Lipids · 2026Article
- A Low-Cost, High-Fat Diet Effectively Induces Obesity and Metabolic Alterations and Diet Normalization Modulates Microbiota in C57BL/6 Mice.Nutrients · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cashew nut oil adds value to the production chain of this Brazilian oilseed. It is a good source of monounsaturated and polyunsaturated fatty acids and bioactive compounds, such as phenolics. This study investigated the effects of cashew nut oil on the metabolism of animals subjected to a high-fat diet. C57BL/6J mice were fed a high-fat diet (12 weeks), then switched to diets containing cashew nut oil, soybean oil, or lard (12 weeks). Diets were characterized for their fatty acid profile. General parameters, metabolic markers, oxidative stress, gene expression, and liver steatosis were evaluated. Oleic acid was predominant in the cashew nut oil-added diet, linoleic acid in the soybean oil-added diet, and palmitic acid in the lard-added diet. Cashew nut oil reduced blood glucose, triglycerides, uric acid, and liver steatosis, and increased SOD expression and activity and catalase activity. Soybean oil reduced blood glucose, total cholesterol, LDL cholesterol, triglycerides, and liver steatosis. Both vegetable oils, rich in unsaturated fatty acids, demonstrated more benefits than animal fat. Cashew nut oil effects may be mediated by the reduction of hepatic fat accumulation and oxidative stress, leading to lower triglyceride levels, improved insulin signaling, and decreased uric acid, probably due to its fatty acid composition, rich in oleic acid. Phenolic compounds may enhance its antioxidant capacity. The quality of fatty acids and the bioactive compounds is a determinant of the metabolic effect of oils. Cashew nut oil may improve lipid metabolism, reduce liver steatosis, and enhance antioxidant effects.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.